CanChip | Custom Tumor-on-Chip & Oncology Validation

Customizable human tumor-on-chip studies designed around the indication and scientific question.

CanChip can define the model, cell types, compound concentrations and readouts around the program objective, fabricate tailored 3D microfluidic chips, establish tumor cell culture/co-culture under physiological flow, execute drug testing and deliver structured analysis. Its validated model library includes liver, pancreas/PDAC, colorectal and prostate applications, while custom model development extends beyond this fixed set subject to technical feasibility.

Study formats

Pilot feasibility studies, expanded dose-response/validation studies and longer-term strategic programs can be scoped according to the development stage.

NAMina Bio integration

NAMina Bio frames the translational question, connects CanChip with complementary NAM layers and readouts, and integrates the evidence into a program-level decision. Scope and pricing are project-specific; use Get a quote.